Mark Pruzanski is CEO & President at INTERCEPT PHARMACEUTICALS, INC. (ICPT). They have made 20 open-market trades across 1 company since 2013, most recently 2023-11-08.
CIK 0001559569
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $500K since 2018, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICPT | 618,894 | $11.8M |
Shares reported on the most recent Form 4, priced at the 2021-12-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICPT | SELL · 10b5-1 | 2019-12-31 | 2020-01-03 | $125.00 | $13K | -2.1% | -19.0% | -47.8% |
| ICPT | SELL | 2019-12-26 | 2019-12-30 | $125.00 | $52K | -6.2% | -24.0% | -47.1% |
| ICPT | SELL | 2019-11-25 | 2019-11-27 | $100.00 | $5.0M | +5.9% | +13.4% | -22.0% |
| ICPT | SELL | 2018-11-16 | 2018-11-16 | $101.54 | $2.8M | +4.8% | +0.1% | +5.8% |
| ICPT | SELL | 2018-11-15 | 2018-11-16 | $101.15 | $9.1M | +4.8% | +0.1% | +5.8% |
| ICPT | SELL | 2018-11-15 | 2018-11-16 | $100.50 | $2.3M | +4.8% | +0.1% | +5.8% |
| ICPT | BUY | 2018-04-09 | 2018-04-09 | $64.00 | $500K | -2.0% | +2.0% | +33.4% |
| ICPT | SELL | 2017-10-02 | 2017-10-04 | $58.87 | $180K | -2.6% | -5.9% | -18.5% |
| ICPT | SELL | 2017-07-03 | 2017-07-05 | $121.78 | $349K | +1.6% | -12.9% | -46.6% |
| ICPT | SELL | 2017-06-26 | 2017-06-28 | $130.80 | $10.5M | +1.8% | +9.9% | -52.1% |
| ICPT | SELL | 2017-04-03 | 2017-04-05 | $136.85 | $137 | -2.8% | +8.1% | +13.2% |
| ICPT | SELL | 2017-01-03 | 2017-01-05 | $103.92 | $582K | +9.5% | +6.5% | +3.4% |
| ICPT | SELL | 2016-10-03 | 2016-10-05 | $163.20 | $230K | -9.3% | -35.9% | -32.6% |
| ICPT | SELL | 2016-09-20 | 2016-09-22 | $165.00 | $5.8M | -9.7% | -22.2% | -38.4% |
| ICPT | SELL | 2016-07-05 | 2016-07-07 | $145.11 | $207K | +1.4% | +12.6% | +7.4% |
| ICPT | SELL | 2016-04-04 | 2016-04-06 | $130.76 | $185K | -8.4% | -18.6% | -12.4% |
| ICPT | SELL | 2016-01-04 | 2016-01-05 | $145.90 | $602K | -18.7% | -31.6% | -10.8% |
| ICPT | SELL | 2015-10-02 | 2015-10-05 | $159.04 | $27K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2015-07-10 | 2015-07-14 | $250.00 | $3.1M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2015-07-02 | 2015-07-07 | $236.26 | $37K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2015-05-14 | 2015-05-18 | $300.00 | $1.5M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2015-05-01 | 2015-05-05 | $253.56 | $3.2M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2015-04-02 | 2015-04-03 | $277.70 | $44K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2015-01-05 | 2015-01-07 | $176.49 | $81K | -17.1% | +1.2% | +1.2% |
| ICPT | SELL · 10b5-1 | 2014-11-03 | 2014-11-05 | $259.41 | $2.6M | -17.1% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.